Mechanism and role of membrane fusion by the atlastin GTPase

atlastin GTPase 膜融合的机制和作用

基本信息

  • 批准号:
    8760551
  • 负责人:
  • 金额:
    $ 24.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Membrane fusion is an essential process. Studies on viral and SNARE fusion catalysts have revealed a common strategy to overcoming the energy barrier to fusion, wherein favorable protein-folding reactions within complexes anchored in opposing membranes drive lipid bilayers together. However, a potentially new paradigm has arisen with discovery that atlastin (ATL), a membrane-anchored dynamin-related GTPase, can trigger fusion of synthetic liposomes, and is required for the branched morphology of the ER. ATL is unique because it is a mechanochemical enzyme that directly couples hydrolysis of GTP to fusion catalysis. Importantly there is not yet agreement on how this works. Is the initial membrane-tethering event upstream or downstream of GTP hydrolysis? Is nucleotide hydrolysis coupled to tethering, or fusion? Does the power stroke-like crossover conformation serve to tether membranes or to fuse them? What is the role of Pi release? This proposal is directed at answering these mechanistic questions. In aim 1 we have established a membrane-tethering assay, based on dynamic light scattering and cryo-electron microscopy, to measure tethering apart from fusion. This assay is being used to determine whether the initial tethering step requires GTP hydrolysis and/or crossover. Preliminary results indicate that tethering depends strictly on hydrolysis of GTP, ruling out a model in which a GTP-bound head contact mediates tethering upstream of hydrolysis. Whether crossover is also required for the tethering event is currently being tested. The result will help tease apart whether crossover contributes more to the tethering or the fusion step. In aim 2 we will use stopped-flow and quench-flow approaches to better understand the coupling between GTP hydrolysis, Pi release, crossover dimer formation and lipid mixing. Because much of our analysis will focus on ATL that is stably integrated into the lipid bilayer, the outcomes should give insights into conformational coupling for the full-length ATL protein in the context of the fusion reaction, thereby helping to distinguih amongst several contrasting models currently in the field. Finally, in aim 3 we will characterize a collection of known functional mutations in ATL1 that cause the motor neurological disease hereditary spastic paraplegia HSP. These will be assayed for in vitro fusion activity as well as for ER network forming activity in cells. Further characterization of mutants, defective in fusion per se, may give further insights into the fusion mechanism; whereas, characterization of mutants that can fuse membranes but yet cannot mediate network formation, may reveal new cellular regulatory mechanisms for ATL-catalyzed fusion. Because mutations in human ATL1 cause the motor neurological disorder HSP whose basis is not understood, these studies have the potential to shed light on disease causality and possibly also impact its therapeutics.
描述(由申请人提供):膜融合是一个重要的过程。对病毒和SNARE融合催化剂的研究揭示了克服融合能量障碍的共同策略,其中锚定在相对膜中的复合物内的有利蛋白质折叠反应将脂质双层驱动在一起。然而,一个潜在的新的范例已经出现,发现atlastin(ATL),膜锚定的动力蛋白相关的GTdR,可以触发合成脂质体的融合,并需要为ER的分支形态。ATL是独特的,因为它是一种机械化学酶,直接将GTP水解与融合催化偶联。重要的是,尚未就如何运作达成一致意见。初始的膜束缚事件是在GTP水解的上游还是下游?核苷酸水解与束缚或融合耦合吗?这种类似于强力划动的交叉构象是用来束缚膜还是用来融合膜?Pi释放的作用是什么?本建议旨在回答这些机械问题。在目标1中,我们建立了一个膜拴系测定,基于动态光散射和冷冻电子显微镜,测量拴系除了融合。本试验用于确定初始拴系步骤是否需要GTP水解和/或交叉。初步结果表明,拴系严格依赖于水解的GTP,排除了一个模型,其中GTP结合的头部接触介导拴系上游的水解。目前正在测试网络共享事件是否也需要交叉。结果将有助于梳理出交叉对系留或融合步骤的贡献更大。在目标2中,我们将使用停流和猝灭流方法来更好地理解GTP水解、Pi释放、交叉二聚体形成和脂质混合之间的耦合。由于我们的大部分分析将集中在ATL,是稳定地整合到脂质双层,结果应该给的融合反应的情况下,全长ATL蛋白的构象耦合的见解,从而有助于目前在该领域中的几个对比模型之间的竞争。最后,在目标3中,我们将描述 收集了导致运动神经疾病遗传性痉挛性截瘫HSP的ATL 1中已知的功能突变。将测定这些的体外融合活性以及细胞中的ER网络形成活性。进一步表征的突变体,融合本身的缺陷,可能会给融合机制的进一步见解,而突变体,可以融合膜,但还不能介导网络的形成,表征可能会揭示新的细胞调控机制ATL催化的融合。由于人类ATL 1突变导致运动神经系统疾病HSP,其基础尚不清楚,这些研究有可能揭示疾病的因果关系,并可能影响其治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christina H Lee其他文献

Christina H Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christina H Lee', 18)}}的其他基金

Mechanism and Role of Membrane Fusion by the Atlastin GTPase
Atlastin GTPase 膜融合的机制和作用
  • 批准号:
    10436798
  • 财政年份:
    2014
  • 资助金额:
    $ 24.98万
  • 项目类别:
Mechanism and Role of Membrane Fusion by the Atlastin GTPase - Equipment Supplement
Atlastin GTPase 膜融合的机制和作用 - 设备补充
  • 批准号:
    10581823
  • 财政年份:
    2014
  • 资助金额:
    $ 24.98万
  • 项目类别:
Mechanism and Role of Membrane Fusion by the Atlastin GTPase
Atlastin GTPase 膜融合的机制和作用
  • 批准号:
    10630357
  • 财政年份:
    2014
  • 资助金额:
    $ 24.98万
  • 项目类别:
Mechanism and role of membrane fusion by the atlastin GTPase
atlastin GTPase 膜融合的机制和作用
  • 批准号:
    9071876
  • 财政年份:
    2014
  • 资助金额:
    $ 24.98万
  • 项目类别:
Mechanism and role of membrane fusion by the atlastin GTPase
atlastin GTPase 膜融合的机制和作用
  • 批准号:
    9314318
  • 财政年份:
    2014
  • 资助金额:
    $ 24.98万
  • 项目类别:
IDENTIFICATION OF PROTEINS THAT STRUCTURE THE ENDOPLASMIC RETICULUM
构建内质网的蛋白质的鉴定
  • 批准号:
    8049736
  • 财政年份:
    2010
  • 资助金额:
    $ 24.98万
  • 项目类别:
IDENTIFICATION OF PROTEINS THAT STRUCTURE THE ENDOPLASMIC RETICULUM
构建内质网的蛋白质的鉴定
  • 批准号:
    7873521
  • 财政年份:
    2010
  • 资助金额:
    $ 24.98万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 24.98万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 24.98万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 24.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 24.98万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 24.98万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 24.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了